Sitagliptin / Metformin hydrochloride Mylan Europos Sąjunga - rumunų - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Dimethyl fumarate Mylan Europos Sąjunga - rumunų - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Pirfenidone Viatris Europos Sąjunga - rumunų - EMA (European Medicines Agency)

pirfenidone viatris

viatris limited - pirfenidonă - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresoare - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Dapagliflozin Viatris Europos Sąjunga - rumunų - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - medicamente utilizate în diabet - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 și 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

ISODINIT® RETARD Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

isodinit® retard

pharmaki generics limited - isosorbidi dinitras - compr. elib. prel. - 20mg - vasodilatatoare uitlizate in afectiuni cardiace nitrati organici

LEVODOPA/CARBIDOPA/ENTACAPONA MYLAN 50 mg/12,5 mg/200 mg Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

levodopa/carbidopa/entacapona mylan 50 mg/12,5 mg/200 mg

generics (uk) ltd - combinatii (levodopum+carbidopum+entacaponum) - compr. film. - 50mg/12,5mg/200mg - agenti dopaminergici dopa si derivati

LEVODOPA/CARBIDOPA/ENTACAPONA MYLAN 75 mg/18,75 mg/200 mg Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

levodopa/carbidopa/entacapona mylan 75 mg/18,75 mg/200 mg

generics (uk) ltd - combinatii (levodopum+carbidopum+entacaponum) - compr. film. - 75mg/18,75mg/200mg - agenti dopaminergici dopa si derivati

LEVODOPA/CARBIDOPA/ENTACAPONA MYLAN 100 mg/25 mg/200 mg Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

levodopa/carbidopa/entacapona mylan 100 mg/25 mg/200 mg

generics (uk) ltd - combinatii (levodopum+carbidopum+entacaponum) - compr. film. - 100mg/25mg/200mg - agenti dopaminergici dopa si derivati

LEVODOPA/CARBIDOPA/ENTACAPONA MYLAN 125 mg/31,25 mg/200 mg Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

levodopa/carbidopa/entacapona mylan 125 mg/31,25 mg/200 mg

generics (uk) ltd - combinatii (levodopum+carbidopum+entacaponum) - compr. film. - 125mg/31,25mg/200mg - agenti dopaminergici dopa si derivati

LEVODOPA/CARBIDOPA/ENTACAPONA MYLAN 150 mg/37,5 mg/200 mg Rumunija - rumunų - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

levodopa/carbidopa/entacapona mylan 150 mg/37,5 mg/200 mg

generics (uk) ltd - combinatii (levodopum+carbidopum+entacaponum) - compr. film. - 150mg/37,5mg/200mg - agenti dopaminergici dopa si derivati